Endothelin receptor antagonists: a place in the management of essential hypertension?
Nephrol Dial Transplant
.
2012 Mar;27(3):865-8.
doi: 10.1093/ndt/gfr704.
Epub 2012 Feb 6.
Authors
Michel Burnier
,
Valentina Forni
PMID:
22311858
DOI:
10.1093/ndt/gfr704
No abstract available
Publication types
Editorial
MeSH terms
Antihypertensive Agents / therapeutic use*
Disease Management
Endothelin Receptor Antagonists*
Humans
Hypertension / drug therapy*
Substances
Antihypertensive Agents
Endothelin Receptor Antagonists